{"openapi":"3.1.0","info":{"title":"ChEMBL API","version":"1.0.0","description":"The ChEMBL database of bioactive molecules as an API — the EBI's manually curated knowledgebase of drug-like compounds and their biological activity, powered by the official ChEMBL data API. Look up a compound by its ChEMBL id for its development phase, chemical structure (SMILES, InChIKey), molecular formula and weight, calculated properties (ALogP, polar surface area, hydrogen-bond donors/acceptors, Rule-of-Five violations, QED drug-likeness) and synonyms; search compounds by name; read a biological target with its organism and UniProt protein components; list a drug's mechanisms of action; list its approved and investigational indications (MeSH and EFO terms with development phase); and pull its measured bioactivities (IC50, Ki, EC50, potency…) with values, units, pChEMBL scores, assays and targets. Ideal for drug-discovery and cheminformatics pipelines, medicinal-chemistry and pharmacology tools, target-identification and SAR research, and life-science apps.","contact":{"name":"PremiumApi","url":"https://www.oanor.com/by/premiumapi"}},"servers":[{"url":"https://api.oanor.com/chembl-api","description":"oanor gateway"}],"tags":[{"name":"Compounds"},{"name":"Targets"},{"name":"Pharmacology"},{"name":"Meta"}],"components":{"securitySchemes":{"oanorKey":{"type":"apiKey","in":"header","name":"x-oanor-key","description":"Get your key at https://www.oanor.com/developer/keys"}}},"security":[{"oanorKey":[]}],"paths":{"/v1/molecule":{"get":{"operationId":"get_v1_molecule","tags":["Compounds"],"summary":"A compound by ChEMBL id","description":"","parameters":[{"name":"id","in":"query","required":true,"description":"ChEMBL id, e.g. CHEMBL25","schema":{"type":"string"},"example":"CHEMBL25"}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"molecule":{"id":"CHEMBL25","mw":"180.16","hba":3,"hbd":1,"psa":"63.60","name":"ASPIRIN","oral":true,"type":"Small molecule","alogp":"1.31","smiles":"CC(=O)Oc1ccccc1C(=O)O","formula":"C9H8O4","topical":false,"synonyms":["8-HOUR BAYER","Acetosalic Acid","ACETYLSALIC ACID","ACETYL SALICYLATE","ACETYLSALICYLIC ACID","ACETYLSALICYLIC ACID","ACETYLSALICYLIC ACID (WHO-IP)","ACETYLSALICYLICUM ACIDUM","ACIDUM ACETYLSALICYLICUM","ACIDUM ACETYLSALICYLICUM (WHO-IP)"],"inchi_key":"BSYNRYMUTXBXSQ-UHFFFAOYSA-N","max_phase":"4.0","withdrawn":false,"parenteral":false,"qed_weighted":"0.55","aromatic_rings":1,"first_approval":1950,"ro5_violations":0,"rotatable_bonds":2}},"meta":{"timestamp":"2026-06-01T08:14:01.942Z","request_id":"60194e23-5f13-4cfd-b8ee-5b4e41d065a8"},"status":"ok","message":"Molecule retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/search":{"get":{"operationId":"get_v1_search","tags":["Compounds"],"summary":"Search compounds by name","description":"","parameters":[{"name":"query","in":"query","required":true,"description":"Compound name, e.g. aspirin","schema":{"type":"string"},"example":"aspirin"},{"name":"limit","in":"query","required":false,"description":"Max results (1-50)","schema":{"type":"string"}}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"count":20,"query":"aspirin","results":[{"id":"CHEMBL25","mw":"180.16","name":"ASPIRIN","type":"Small molecule","formula":"C9H8O4","max_phase":"4.0"},{"id":"CHEMBL5314595","mw":"279.34","name":"ASPIRIN TRELAMINE","type":"Small molecule","formula":"C15H21NO4","max_phase":"2.0"},{"id":"CHEMBL5282669","mw":"178.19","formula":"C10H10O3"},{"id":"CHEMBL1697753","mw":"326.35","name":"ASPIRIN DL-LYSINE","type":"Small molecule","formula":"C15H22N2O6","max_phase":"3.0"},{"id":"CHEMBL2260549","mw":"326.35","name":"ASPIRIN EUGENOL ESTER","type":"Small molecule","formula":"C19H18O5"},{"id":"CHEMBL5314596","mw":"315.80","name":"ASPIRIN TRELAMINE HYDROCHLORIDE","type":"Small molecule","formula":"C15H22ClNO4","max_phase":"2.0"},{"id":"CHEMBL2105097","mw":"286.28","name":"GUACETISAL","type":"Small molecule","formula":"C16H14O5","max_phase":"2.0"},{"id":"CHEMBL2296002","mw":"326.35","type":"Small molecule","formula":"C15H22N2O6"},{"id":"CHEMBL458500","mw":"308.29","type":"Small molecule","formula":"C15H16O7"},{"id":"CHEMBL4168118","mw":"292.31","type":"Small molecule","formula":"C15H18NO5"},{"id":"CHEMBL457234","mw":"308.29","type":"Small molecule","formula":"C15H16O7"},{"id":"CHEMBL457443","mw":"428.39","type":"Small molecule","formula":"C22H20O9"},{"id":"CHEMBL568554","mw":"350.32","type":"Small molecule","formula":"C17H18O8"},{"id":"CHEMBL584911","mw":"364.35","type":"Small molecule","formula":"C18H20O8"},{"id":"CHEMBL565421","mw":"376.36","type":"Small molecule","formula":"C19H20O8"},{"id":"CHEMBL567100","mw":"412.39","type":"Small molecule","formula":"C22H20O8"},{"id":"CHEMBL567716","mw":"353.28","type":"Small molecule","formula":"C15H15NO9"},{"id":"CHEMBL565400","mw":"413.38","type":"Small molecule","formula":"C21H19NO8"},{"id":"CHEMBL565401","mw":"487.42","type":"Small molecule","formula":"C23H21NO11"},{"id":"CHEMBL565619","mw":"428.39","type":"Small molecule","formula":"C22H20O9"}]},"meta":{"timestamp":"2026-06-01T08:14:02.769Z","request_id":"4abb12f6-4f67-46f8-bf6b-57697c129b95"},"status":"ok","message":"Search results retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/target":{"get":{"operationId":"get_v1_target","tags":["Targets"],"summary":"A biological target","description":"","parameters":[{"name":"id","in":"query","required":true,"description":"Target ChEMBL id, e.g. CHEMBL204","schema":{"type":"string"},"example":"CHEMBL204"}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"target":{"id":"CHEMBL204","name":"Prothrombin","type":"SINGLE PROTEIN","tax_id":9606,"organism":"Homo sapiens","components":[{"type":"PROTEIN","accession":"P00734","description":"Prothrombin","relationship":"SINGLE PROTEIN"}],"species_group_flag":false}},"meta":{"timestamp":"2026-06-01T08:14:03.516Z","request_id":"f6ee982c-81bb-4038-9c42-e8e3fce17792"},"status":"ok","message":"Target retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/activity":{"get":{"operationId":"get_v1_activity","tags":["Pharmacology"],"summary":"Measured bioactivities for a compound","description":"","parameters":[{"name":"molecule","in":"query","required":true,"description":"Molecule ChEMBL id","schema":{"type":"string"},"example":"CHEMBL25"},{"name":"limit","in":"query","required":false,"description":"Max (1-100)","schema":{"type":"string"}}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"count":25,"total":4087,"molecule":"CHEMBL25","activities":[{"type":"Log K'","value":"1.39","relation":"=","assay_chembl_id":"CHEMBL702885","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL3253","assay_description":"Binding constant against human serum albumin (HSA)"},{"type":"Activity","units":"%","value":"100.0","relation":"=","assay_chembl_id":"CHEMBL771355","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"Antiedema efficacy was measured in male Sprague-Dawley rats relative to aspirin; activity expressed as percent of aspiri"},{"type":"ED25","units":"uM kg-1","value":"402.0","relation":"=","assay_chembl_id":"CHEMBL780106","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"Effective dose of compound to produce 25% inhibition in rat; Value ranges from 326-499"},{"type":"IC50","units":"nM","value":"34600.0","relation":"=","pchembl_value":"4.46","assay_chembl_id":"CHEMBL762032","target_chembl_id":"CHEMBL612545","assay_description":"Inhibitory concentration required against Arachidonic acid (100 uM) induced platelet aggregatory activity"},{"type":"IC50","units":"nM","value":"34900.0","relation":"=","pchembl_value":"4.46","assay_chembl_id":"CHEMBL762033","target_chembl_id":"CHEMBL612545","assay_description":"In vitro inhibition of Collagen (10 ug/mL) induced platelet aggregatory activity."},{"type":"Inhibition","units":"%","value":"81.0","relation":"=","assay_chembl_id":"CHEMBL765149","target_chembl_id":"CHEMBL612545","assay_description":"Percentage inhibition against thrombin induced platelet aggregatory activity"},{"type":"Inhibition","units":"%","value":"2.0","relation":"=","assay_chembl_id":"CHEMBL765148","target_chembl_id":"CHEMBL612545","assay_description":"Percentage inhibition against platelet activating factor (2 ng/mL) induced platelet aggregatory activity"},{"type":"IC50","units":"nM","value":"62500.0","relation":"=","pchembl_value":"4.20","assay_chembl_id":"CHEMBL760085","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL230","assay_description":"Inhibitory concentration in DMSO with purified human Prostaglandin G/H synthase 2 (COX-2)"},{"type":"IC50","units":"nM","value":"12500.0","relation":"=","pchembl_value":"4.90","assay_chembl_id":"CHEMBL764258","target_organism":"Ovis aries","target_chembl_id":"CHEMBL2949","assay_description":"Inhibitory concentration in DMSO with purified ovine Prostaglandin G/H synthase 1 (COX-1)."},{"type":"Dose","units":"mg","value":"325.0","relation":"=","assay_chembl_id":"CHEMBL767504","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL2094253","assay_description":"Evaluated for dose to inhibit Prostaglandin G/H synthase of platelets by about 90% in human"},{"type":"ED50","units":"mg.kg-1","value":"70.0","relation":"=","assay_chembl_id":"CHEMBL733962","target_organism":"Mus musculus","target_chembl_id":"CHEMBL375","assay_description":"Analgesic activity was assessed from the ability to inhibit phenylquinone-induced writhing in mouse at a dose of 70 mg/k"},{"type":"ED50","units":"mg.kg-1","value":"42.3","relation":"=","assay_chembl_id":"CHEMBL735173","target_organism":"Mus musculus","target_chembl_id":"CHEMBL375","assay_description":"Effective dose required for writhing response in mouse after 20 minutes on ig administration"},{"type":"EC50","units":"ug.mL-1","value":"494.0","relation":"=","assay_chembl_id":"CHEMBL840552","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL372","assay_description":"In vitro inhibition of collagen-induced human platelet aggregation."},{"type":"Relative activity","value":"1.0","relation":"=","assay_chembl_id":"CHEMBL841426","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL372","assay_description":"Relative activity (compared to acetylsalicylic acid) for in vitro inhibition of collagen-induced human platelet aggregat"},{"type":"ED33","units":"mg kg-1","value":"233.0","relation":"=","assay_chembl_id":"CHEMBL847716","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"Ex vivo inhibition of collagen-induced rat platelet aggregation after peroral administration"},{"type":"Relative activity","value":"1.0","relation":"=","assay_chembl_id":"CHEMBL849664","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"Activity relative to dihydralazine for in vitro hypotensive activity in anesthetized rats"},{"type":"Ratio","value":"0.47","relation":"=","assay_chembl_id":"CHEMBL848423","target_chembl_id":"CHEMBL612545","assay_description":"In vitro inhibition of collagen induced aggregation of human plateles and the ratio of ED33 to EC50 was reported"},{"type":"Inhibition","units":"%","value":"50.0","relation":"=","assay_chembl_id":"CHEMBL724465","target_organism":"Mus musculus","target_chembl_id":"CHEMBL375","assay_description":"Analgesic activity was measured on phenylquinone writhing in mice at 50 mg/kg subcutaneous dose"},{"type":"MIC","units":"ug.mL-1","assay_chembl_id":"CHEMBL812595","target_organism":"Trichomonas vaginalis","target_chembl_id":"CHEMBL612884","assay_description":"Compound was measured as concentration of compound required for 90% growth inhibition of Trichomonas vaginalis; ND=No da"},{"type":"ED50","units":"mg.kg-1","value":"305.0","relation":"=","assay_chembl_id":"CHEMBL782421","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"Antiinflammatory activity against adjuvant induced arthritis in male charles river rats"},{"type":"IC50","units":"nM","value":"1000000.0","relation":">","assay_chembl_id":"CHEMBL771612","target_chembl_id":"CHEMBL612545","assay_description":"In vitro inhibitory activity against Adenosine diphosphate (ADP) induced rabbit platelet aggregation"},{"type":"IC50","units":"nM","value":"1000000.0","relation":">","assay_chembl_id":"CHEMBL771613","target_organism":"Oryctolagus cuniculus","target_chembl_id":"CHEMBL374","assay_description":"In vitro inhibitory activity against collagen induced rabbit platelet aggregation"},{"type":"Inhibition","units":"%","value":"33.0","relation":"=","assay_chembl_id":"CHEMBL738536","target_organism":"Mus musculus","target_chembl_id":"CHEMBL375","assay_description":"In vivo anti-thrombotic activity was evaluated by the inhibition of pulmonary thromboembolism model in mice at a dose of"},{"type":"Inhibition","units":"%","value":"16.0","relation":"=","assay_chembl_id":"CHEMBL787143","target_organism":"Rattus norvegicus","target_chembl_id":"CHEMBL376","assay_description":"In vivo anti-hyperplastic activity was evaluated by the inhibition of balloon injury model in rats at a dose of 30 mg/kg"},{"type":"Absorption","units":"%","value":"100.0","relation":"=","assay_chembl_id":"CHEMBL628746","target_organism":"Homo sapiens","target_chembl_id":"CHEMBL372","assay_description":"Human absorption A (%)"}]},"meta":{"timestamp":"2026-06-01T08:14:04.160Z","request_id":"0fd5d9a9-3fcf-4663-b933-739f62ee5c32"},"status":"ok","message":"Bioactivities retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/indications":{"get":{"operationId":"get_v1_indications","tags":["Pharmacology"],"summary":"A drug's indications","description":"","parameters":[{"name":"molecule","in":"query","required":true,"description":"Molecule ChEMBL id","schema":{"type":"string"},"example":"CHEMBL25"},{"name":"limit","in":"query","required":false,"description":"Max (1-200)","schema":{"type":"string"}}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"count":49,"molecule":"CHEMBL25","indications":[{"mesh_id":"D001281","efo_term":"atrial fibrillation","max_phase":"3.0","mesh_heading":"Atrial Fibrillation"},{"mesh_id":"D004381","efo_term":"duodenal ulcer","max_phase":"2.0","mesh_heading":"Duodenal Ulcer"},{"mesh_id":"D005334","efo_term":"Fever","max_phase":"4.0","mesh_heading":"Fever"},{"mesh_id":"D006973","efo_term":"hypertension","max_phase":"3.0","mesh_heading":"Hypertension"},{"mesh_id":"D058729","efo_term":"peripheral arterial disease","max_phase":"3.0","mesh_heading":"Peripheral Arterial Disease"},{"mesh_id":"D007246","efo_term":"infertility","max_phase":"3.0","mesh_heading":"Infertility"},{"mesh_id":"D020521","efo_term":"stroke","max_phase":"4.0","mesh_heading":"Stroke"},{"mesh_id":"D010146","efo_term":"pain","max_phase":"4.0","mesh_heading":"Pain"},{"mesh_id":"D011225","efo_term":"preeclampsia","max_phase":"3.0","mesh_heading":"Pre-Eclampsia"},{"mesh_id":"D002294","efo_term":"squamous cell carcinoma","max_phase":"3.0","mesh_heading":"Carcinoma, Squamous Cell"},{"mesh_id":"D002318","efo_term":"cardiovascular disease","max_phase":"3.0","mesh_heading":"Cardiovascular Diseases"},{"mesh_id":"D011618","efo_term":"psychosis","max_phase":"3.0","mesh_heading":"Psychotic Disorders"},{"mesh_id":"D006333","efo_term":"heart failure","max_phase":"3.0","mesh_heading":"Heart Failure"},{"mesh_id":"D006976","efo_term":"pulmonary arterial hypertension","max_phase":"2.0","mesh_heading":"Hypertension, Pulmonary"},{"mesh_id":"D055371","efo_term":"acute lung injury","max_phase":"2.0","mesh_heading":"Acute Lung Injury"},{"mesh_id":"D005909","efo_term":"glioblastoma multiforme","max_phase":"2.0","mesh_heading":"Glioblastoma"},{"mesh_id":"D015658","efo_term":"HIV infection","max_phase":"2.0","mesh_heading":"HIV Infections"},{"mesh_id":"D050197","efo_term":"atherosclerosis","max_phase":"3.0","mesh_heading":"Atherosclerosis"},{"mesh_id":"D054556","efo_term":"venous thromboembolism","max_phase":"3.0","mesh_heading":"Venous Thromboembolism"},{"mesh_id":"D029424","efo_term":"chronic obstructive pulmonary disease","max_phase":"3.0","mesh_heading":"Pulmonary Disease, Chronic Obstructive"},{"mesh_id":"D012128","efo_term":"acute respiratory distress syndrome","max_phase":"2.0","mesh_heading":"Respiratory Distress Syndrome"},{"mesh_id":"D013927","efo_term":"Recurrent thrombophlebitis","max_phase":"4.0","mesh_heading":"Thrombosis"},{"mesh_id":"D001943","efo_term":"breast neoplasm","max_phase":"3.0","mesh_heading":"Breast Neoplasms"},{"mesh_id":"D011471","efo_term":"prostate carcinoma","max_phase":"2.0","mesh_heading":"Prostatic Neoplasms"},{"mesh_id":"D002289","efo_term":"non-small cell lung carcinoma","max_phase":"3.0","mesh_heading":"Carcinoma, Non-Small-Cell Lung"},{"mesh_id":"D011014","efo_term":"pneumonia","max_phase":"3.0","mesh_heading":"Pneumonia"},{"mesh_id":"D014947","efo_term":"injury","max_phase":"3.0","mesh_heading":"Wounds and Injuries"},{"mesh_id":"D051436","efo_term":"chronic kidney disease","max_phase":"3.0","mesh_heading":"Renal Insufficiency, Chronic"},{"mesh_id":"D007511","efo_term":"ischemia","max_phase":"3.0","mesh_heading":"Ischemia"},{"mesh_id":"D054058","efo_term":"acute coronary syndrome","max_phase":"3.0","mesh_heading":"Acute Coronary Syndrome"},{"mesh_id":"D020246","efo_term":"Venous thrombosis","max_phase":"2.0","mesh_heading":"Venous Thrombosis"},{"mesh_id":"D006331","efo_term":"heart disease","max_phase":"3.0","mesh_heading":"Heart Diseases"},{"mesh_id":"D007319","efo_term":"insomnia","max_phase":"0.5","mesh_heading":"Sleep Initiation and Maintenance Disorders"},{"mesh_id":"D003920","efo_term":"diabetes mellitus","max_phase":"3.0","mesh_heading":"Diabetes Mellitus"},{"mesh_id":"D002312","efo_term":"hypertrophic cardiomyopathy","max_phase":"3.0","mesh_heading":"Cardiomyopathy, Hypertrophic"},{"mesh_id":"D011087","efo_term":"polycythemia vera","max_phase":"3.0","mesh_heading":"Polycythemia Vera"},{"mesh_id":"D009369","efo_term":"neoplasm","max_phase":"2.0","mesh_heading":"Neoplasms"},{"mesh_id":"D001471","efo_term":"Barrett's esophagus","max_phase":"2.0","mesh_heading":"Barrett Esophagus"},{"mesh_id":"D014652","efo_term":"vascular disease","max_phase":"3.0","mesh_heading":"Vascular Diseases"},{"mesh_id":"D009203","efo_term":"myocardial infarction","max_phase":"4.0","mesh_heading":"Myocardial Infarction"},{"mesh_id":"D000026","efo_term":"habitual abortion","max_phase":"3.0","mesh_heading":"Abortion, Habitual"},{"mesh_id":"D011247","efo_term":"pregnancy","max_phase":"2.0","mesh_heading":"Pregnancy"},{"mesh_id":"D012170","efo_term":"retinal vein occlusion","max_phase":"3.0","mesh_heading":"Retinal Vein Occlusion"},{"mesh_id":"D000236","efo_term":"colorectal adenoma","max_phase":"2.0","mesh_heading":"Adenoma"},{"mesh_id":"D014029","efo_term":"nicotine dependence","max_phase":"2.0","mesh_heading":"Tobacco Use Disorder"},{"mesh_id":"D060050","efo_term":"angina pectoris","max_phase":"3.0","mesh_heading":"Angina, Stable"},{"mesh_id":"D006528","efo_term":"hepatocellular carcinoma","max_phase":"3.0","mesh_heading":"Carcinoma, Hepatocellular"},{"mesh_id":"D024821","efo_term":"metabolic syndrome","max_phase":"2.0","mesh_heading":"Metabolic Syndrome"},{"mesh_id":"D001024","efo_term":"aortic stenosis","max_phase":"3.0","mesh_heading":"Aortic Valve Stenosis"}]},"meta":{"timestamp":"2026-06-01T08:14:04.288Z","request_id":"5075e5a3-067e-4444-87fd-23c5bb302b66"},"status":"ok","message":"Indications retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/mechanism":{"get":{"operationId":"get_v1_mechanism","tags":["Pharmacology"],"summary":"A drug's mechanisms of action","description":"","parameters":[{"name":"molecule","in":"query","required":true,"description":"Molecule ChEMBL id","schema":{"type":"string"},"example":"CHEMBL25"}],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"count":1,"molecule":"CHEMBL25","mechanisms":[{"max_phase":4,"action_type":"INHIBITOR","target_chembl_id":"CHEMBL2094253","direct_interaction":1,"mechanism_of_action":"Cyclooxygenase inhibitor"}]},"meta":{"timestamp":"2026-06-01T08:14:04.397Z","request_id":"c5b06413-83e9-4533-8a32-62b19359048f"},"status":"ok","message":"Mechanisms retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}},"/v1/meta":{"get":{"operationId":"get_v1_meta","tags":["Meta"],"summary":"Usage notes","description":"","parameters":[],"security":[{"oanorKey":[]}],"responses":{"200":{"description":"OK","content":{"application/json":{"example":{"data":{"note":"The ChEMBL bioactive-molecule database. /v1/molecule?id=CHEMBL25 = a compound (ASPIRIN: development max_phase, structure SMILES & InChIKey, molecular formula & weight, ALogP, PSA, H-bond donors/acceptors, Rule-of-5 violations, QED); /v1/search?query=aspirin = search compounds by name; /v1/target?id=CHEMBL204 = a biological target (protein, organism, UniProt components); /v1/mechanism?molecule=CHEMBL25 = a drug's mechanisms of action (target & action type); /v1/indications?molecule=CHEMBL25 = its approved/investigational indications (MeSH & EFO terms, max phase); /v1/activity?molecule=CHEMBL25 = measured bioactivities (IC50, Ki, potency… with value, units, pChEMBL, assay & target). Ids look like CHEMBL25. Data from EBI ChEMBL. For FDA drug labels see the Drug API; for protein function the UniProt API.","source":"EBI ChEMBL data API (ebi.ac.uk/chembl)","endpoints":["/v1/molecule","/v1/search","/v1/target","/v1/mechanism","/v1/indications","/v1/activity","/v1/meta"]},"meta":{"timestamp":"2026-06-01T08:14:04.450Z","request_id":"f6bc21d7-4968-4989-b9c4-2143ff2a4d85"},"status":"ok","message":"Meta retrieved","success":true}}}},"401":{"description":"Missing or invalid x-oanor-key header"},"402":{"description":"Active subscription required"},"429":{"description":"Rate-limit or monthly quota reached"},"502":{"description":"Upstream did not respond"}}}}},"x-oanor-pricing":[{"slug":"free","name":"Free","price_cents_month":0,"monthly_call_quota":540,"rps_limit":2,"hard_limit":true},{"slug":"starter","name":"Starter","price_cents_month":730,"monthly_call_quota":18500,"rps_limit":6,"hard_limit":true},{"slug":"pro","name":"Pro","price_cents_month":2200,"monthly_call_quota":87000,"rps_limit":15,"hard_limit":true},{"slug":"mega","name":"Mega","price_cents_month":6050,"monthly_call_quota":335000,"rps_limit":40,"hard_limit":true}],"x-oanor-marketplace-url":"https://www.oanor.com/api/chembl-api"}